Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Nichiiren to Support Mr Takemi in Next Election of Upper House
September 4, 2006
- Next Medical Fee Revision "Won't Be Too Severe": Prof. Nishimura
September 4, 2006
- REGULATORY NEWS IN BRIEF
September 4, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 4, 2006
- Direct Deal between Makers, Med. Institutions Conditionally Approvable: Mr Katagiri of FTC
September 4, 2006
- MEDICAL DEVICE NEWS IN BRIEF
September 4, 2006
- Blopress Top-selling Drug in April-June: IMS Japan
September 4, 2006
- SELF-MEDICATION NEWS IN BRIEF
September 4, 2006
- Drug Wholesalers' Gross Profit Ratio Hits Record Low: FJPWA
September 4, 2006
- FPMAJ to Propose System That May Raise NHI Prices of Existing Drugs: Mr Nagano
September 4, 2006
- DSP, Sumitomo Chemical Agree with Pfizer on Settlement of Amlodin Lawsuit
September 4, 2006
- BUSINESS NEWS IN BRIEF
September 4, 2006
- NEW PRODUCTS
September 4, 2006
- IMMD Completes PI Trial of IkB Kinase Inhibitor IMD-1041
September 4, 2006
- Bribery Affairs in Relation to Clinical Trials Explained: Ihoken Seminar
September 4, 2006
- R&D NEWS IN BRIEF
September 4, 2006
- Nippon Chemiphar's GE Drug Sales Could Reach \100 Bil. in FY2006
September 4, 2006
- Generics Account for 10.1% of Cost of Drugs in Non-legal Rx Issued by Clinics
September 4, 2006
- SURVEY 4 articles
September 4, 2006
- GENERIC NEWS IN BRIEF Korosho's FY2007 Budget to Promote Use of GE Drugs
September 4, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…